Role of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome | Zendy

Mahesh Anantha Narayanan | Zendy; Santiago García | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome

Author(s) -

Mahesh Anantha Narayanan,

Santiago García

Publication year - 2019

Publication title -

us cardiology review

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.148

H-Index - 3

eISSN - 1758-390X

pISSN - 1758-3896

DOI - 10.15420/usc.2018.16.1

Subject(s) - acute coronary syndrome , medicine , chest pain , troponin , emergency department , cardiology , biomarker , intensive care medicine , emergency medicine , myocardial infarction , biochemistry , chemistry , psychiatry

Chest pain is one of the most common reasons for an emergency room (ER) visit in the US, with almost 6 million ER visits annually. High-sensitivity cardiac troponin (hscTn) assays have the ability to rapidly rule in or rule out acute coronary syndrome with improved sensitivity, and they are increasingly being used. Though hscTn assays have been approved for use in European, Australian, and Canadian guidelines since 2010, the FDA only approved their use in 2017. There is no consensus on how to compare the results from various hscTn assays. A literature review was performed to analyze the advantages and limitations of using hscTn as a standard biomarker to evaluate patients with suspected ACS in the emergency setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research